Keto and Parkinson’s Disease: Current Research and Neuroprotective Evidence
Important Note: This article presents preliminary research only. Parkinson’s disease treatment requires specialist neurological care. Never modify treatment without consulting your neurologist.
Parkinson’s disease (PD) is the second most common neurodegenerative condition after Alzheimer’s, affecting over 145,000 people in the UK. Mitochondrial dysfunction and oxidative stress in dopaminergic neurons are central to its pathology.
The Energy Deficit in Parkinson’s
Postmortem studies of Parkinson’s brains consistently show Complex I mitochondrial dysfunction — impaired ATP production in precisely the neurons that degenerate. If these neurons cannot use glucose efficiently, ketones offer an alternative fuel source.
Clinical Evidence
A 2018 pilot study in NPJ Parkinson’s Disease showed improvements in motor and non-motor symptoms in PD patients following a ketogenic diet, with a 41% improvement on the Unified Parkinson’s Disease Rating Scale.
Animal Research
Multiple rodent models of Parkinson’s show that ketones protect dopaminergic neurons from the neurotoxins used to model PD, and that ketogenic diets reduce dopaminergic cell death.